Advisor Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$57.4M Sell
393,029
-2,075
-0.5% -$281K 0.4% 42
2019
Q3
$51.2M Sell
395,104
-19,056
-5% -$2.51M 0.38% 46
2019
Q2
$57.7M Buy
414,160
+4,426
+1% +$613K 0.44% 40
2019
Q1
$57.3M Sell
409,734
-1,711
-0.4% -$229K 0.47% 37
2018
Q4
$53.1M Buy
411,445
+51,399
+14% +$7.17M 0.52% 34
2018
Q3
$49.8M Buy
360,046
+49,923
+16% +$6.63M 0.5% 36
2018
Q2
$37.7M Sell
310,123
-14,849
-5% -$1.85M 0.52% 30
2018
Q1
$41.7M Sell
324,972
-6,640
-2% -$897K 0.57% 26
2017
Q4
$46.4M Buy
331,612
+26,951
+9% +$3.75M 0.62% 25
2017
Q3
$39.6M Buy
304,661
+6,972
+2% +$924K 0.62% 23
2017
Q2
$39.4M Buy
297,689
+16,559
+6% +$2.11M 0.69% 17
2017
Q1
$35M Buy
281,130
+16,805
+6% +$2.01M 0.71% 17
2016
Q4
$30.5M Buy
264,325
+12,504
+5% +$1.44M 0.69% 17
2016
Q3
$29.8M Buy
251,821
+15,946
+7% +$1.93M 0.72% 15
2016
Q2
$28.6M Buy
+235,875
New +$26.8M 0.75% 10

Other funds holding JNJ

Advisor Group's JNJ Position: Q4 2019 in Review

Advisor Group reduced its Johnson & Johnson (JNJ) stake by 0.53% in Q4 2019, selling an estimated $281K and leaving 393,029 shares worth $57.4M. The position accounts for 0.4% of the portfolio, ranked #42.

Advisor Group first reported a position in JNJ in Q2 2016 and has held it in 15 quarters since. The position peaked at $57.7M in Q2 2019. 2,990 funds tracked by Wall St. Rank hold JNJ as of Q4 2019.

  • Advisor Group held 393,029 shares of Johnson & Johnson worth $57.4M as of Q4 2019.
  • Advisor Group sold 2,075 Johnson & Johnson shares in Q4 2019, an estimated $281K.
  • Johnson & Johnson made up 0.4% of Advisor Group's portfolio in Q4 2019, its #42 holding.
  • Advisor Group first reported a position in Johnson & Johnson in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Johnson & Johnson position peaked at $57.7M in Q2 2019.
  • 2,990 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.